24 October 2023
Latham & Watkins Advises Arcutis Biotherapeutics on Pricing of US$100 Million Public Offering
Advising firms
Deal team
13 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Ross McAloon Lead | Latham & Watkins LLP | Partner | capital markets | Not stated |
| Shayne Kennedy Lead | Latham & Watkins LLP | Partner | capital markets | Not stated |
| Mekbeb Hagos | Latham & Watkins LLP | Associate | capital markets | Orange County |
| David Stepovich | Latham & Watkins LLP | Associate | capital markets | Orange County |
| Grace Lee | Latham & Watkins LLP | Partner | tax | Bay Area |
| Gregory Conyers | Latham & Watkins LLP | Associate | tax | Not stated |
| Rasha Suleiman | Latham & Watkins LLP | Associate | tax | Not stated |
| Elizabeth Richards | Latham & Watkins LLP | Partner | healthcare and life sciences | Washington, D.C. |
| Heather Deixler | Latham & Watkins LLP | Partner | healthcare and life sciences | Bay Area |
| Betty Pang | Latham & Watkins LLP | Partner | healthcare and life sciences | Bay Area |
| Chad Jennings | Latham & Watkins LLP | Counsel | healthcare and life sciences | Washington, D.C. |
| Kiera Murphy | Latham & Watkins LLP | Associate | healthcare and life sciences | San Diego |
| Mitch Bennett | Latham & Watkins LLP | Associate | healthcare and life sciences | Bay Area |
Stated terms
- Stated value
- USD 100m (US$100.0 million)
- What the figure measures
- Issue size
- Client
- Arcutis BiotherapeuticsIssuer
- Counterparties
- Not stated